574 Results (Page 20 of 23)
Brazil Markets Research Reports
Brazil Ambulatory Surgery Center Market Analysis
Brazil Ambulatory Surgery Center Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Ambulatory Surgery Center is expanding as a result of Increasing demand for minimal invasive surgeries and rising healthcare expenditure. This demand is fueling the development of better surgical devices and methods for effective and accurate outcomes of ambulatory surgeries. Some of the key players in the global ambulatory surgery center market include Community Health Systems, Inc.; Envision Healthcare Corporation; Terveystalo; Tenet Healthcare Corporation; MEDNAX Services, Inc.; TeamHealth; Quorum Health Corporation; UnitedHealth Group; Surgery Partners; and Healthway Medical Group.
Brazil Antimicrobial Susceptibility Testing Market Analysis
Brazil Antimicrobial Susceptibility Testing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Antimicrobial Susceptibility Testing is expanding as a result of increasing infectious diseases and rising research and development funding globally. This demand is fueling the development of better tools and methods for antimicrobial susceptibility testing market. Some of the key players in the global Antimicrobial Susceptibility Testing Market include Bio-Rad Laboratories Inc.; Merck & Co., Inc.; Thermo Fisher Scientific Inc.; Danaher Corporation; BD; bioM?rieux SA; Creative Diagnostics; Hi-Media Laboratories Pvt. Ltd.; ELITechGroup; and F. Hoffmann-La Roche Ltd.
Brazil Appetite (Eating) Disorder Market Analysis
Brazil Appetite Disorder Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Appetite Disorder is expanding as a result of rising psychiatric illness and increasing prevalence of eating disorders. This demand is fueling the development of better medication and treatment procedures for the early intervention of appetite disorders.Some of the key players in the global Appetite Disorder Market include Bausch & Lomb Incorporated, Somerset Therapeutics, LLC, Equip, Teva Pharmaceuticals Industries Ltd, Mylan N.V., Pfizer Inc., Amneal Pharmaceutical LLC, Sun Pharmaceutical Industries Ltd, Moriah Behavioral Health, and Eli Lilly and Company.
Brazil Biomaterial Wound Dressing Market Analysis
Brazil Biomaterial Wound Dressing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Biomaterial Wound Dressing is expanding as a result of rising healthcare expenditure by government and the increasing burden of chronic wounds. This will create a rapid demand for Biomaterial Wound Dressing in the years to come. Some of the key players in the global Biomaterial Wound Dressing include 3M Company, Molnlycke Health Care AB, Smith & Nephew PLC, ConvaTec Group, DermaRite Industries LLC, B. Braun Melsungen AG, Hollister Incorporated, Integra LifeSciences Holdings Corporation, Johnson & Johnson, and Medtronic PLC.
Brazil Blood Gas and Electrolyte Analyzers Market Analysis
Brazil Blood Gas and Electrolyte Analyzers Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Blood Gas and Electrolyte Analyzers is expanding as a result of rising geriatric population, increased number of patients in emergency rooms. This rise is fueling the growth of Blood Gas and Electrolyte Analyzers market. Some of the key players in the global Blood Gas and Electrolyte Analyzers Market include Abbott Laboratories, Danaher Corporation, F. Hoffmann-La Roche AG, Convergent Technologies GmbH & Co. KG, Radiometer Medical, Medica Corporation, Siemens AG, Nova Biomedical, Sensa Core Medical Instrumentation Pvt. Ltd., Transasia Bio-Medicals Ltd., and Werfen Science SA.
Brazil Physiotherapy Market Analysis
Brazil's physiotherapy market size was valued at $1.33 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.85% from 2022 to 2030 and will reach $2.26 Bn in 2030. Brazil's physiotherapy market is expected to grow due to, the increasing geriatric population, and increasing chronic disease prevalence. The market is segmented by Product Type, Application Type and End User. The major players in the Brazilian physiotherapy market are BTL Industries, DJO Global, Inc., EMS Physio Ltd., and others.
Brazil Home Healthcare Market Analysis
Brazil's home healthcare market was valued at $9.07 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.93% from 2022 to 2030 and will reach $17.97 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the ageing population. The market is segmented by component and product. Some key players in this market are Fleury Home Healthcare, Casa de Repouso, Home Care, Medcare Home Healthcare, Healthway Home Healthcare, and Inca Home Healthcare.
Brazil Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Brazil Oncology Therapeutics Market will reach a value of $9.3 Bn from $4.5 Bn in 2022, growing at a CAGR of 9.4% during 2022-2030. The Oncology Therapeutics Market in Brazil is dominated by a few domestic pharmaceutical companies such as Cristalia, Eurofarma, and Ache Laboratorios. The Oncology Therapeutics Market in Brazil is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Brazil Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
Brazil Medical Devices Market Analysis
This report presents a strategic analysis of the Brazil Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Brazil Medical Devices Market, offering unmatched value, accuracy and expert insights.
Brazil Pharmaceutical Market Analysis
This report presents a strategic analysis of the Brazil Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Brazil Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
Brazil Digital Health Market Analysis
Brazil's Digital Health market is projected to grow from $5.28 Bn in 2022 to $22.08 Bn by 2030, registering a CAGR of 19.6% during the forecast period of 2022-2030. Driven by the increasing prevalence of chronic diseases and the penetration of smartphones the market is expected to grow in the near future. The market is segmented by solution, deployment, and by end-use. Some of the major players include WeCancer Technological Solutions Ltd., Memed & Conexa Saúde.
Brazil Orphan Diseases Drugs Market Analysis
Brazil's Orphan Diseases Drugs Market is projected to grow from $3.870 Bn in 2022 to $9.114 Bn by 2030, registering a CAGR of 11.30% during the forecast period of 2022-2030. In Brazil, there is a significant population affected by rare diseases, with estimates suggesting that around 8 Mn Brazilians suffer from one of the more than 7,000 rare diseases currently known. The most common types of rare diseases in Brazil include genetic disorders, neurological conditions, and blood disorders. The key players in the Brazil orphan diseases drugs market include Pfizer, Roche Holding, Sanofi, Novartis International, Merck, and Amgen.
Brazil Clinical Diagnostics Market Analysis
Brazil's clinical diagnostic market was valued at $1.7 Bn in 2022 and is estimated to expand at a CAGR of 7% from 2022-30 and will reach $2.9 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Diagnósticos da América S.A. (DASA), Quest Diagnostics Incorporated, Synlab Solutions in Diagnostics, Grupo Fleury, Hospital Israelita Albert Einstein, Alliar, Boris Berenstein Diagnostic Center, Clinica da Imagem do Tocantis, Abramed, Hermes Pardini Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Roche, and others.
Brazil Dermatology Drugs Market Analysis
By 2030, it is anticipated that the Brazil dermatology drugs market will reach a value of $1037.35 Mn from $425 Mn in 2022, growing at a CAGR of 11.8% during 2022-2030. The market is primarily dominated by local players such as Neo Química, Eurofarma, and EMS S.A. The market is driven by Telemedicine, OTC, and government regulations. The dermatology drug market in Brazil is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
Brazil In Vitro Fertilisation (IVF) Service Market Analysis
This report presents a strategic analysis of the Brazil In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Brazil In Vitro Fertilisation (IVF) Service Market, offering unmatched value, accuracy and expert insights.
Brazil Healthcare Insurance Market Analysis
Brazil's healthcare insurance market is projected to grow from $50.66 Bn in 2022 to $98.01 Bn by 2030, registering a CAGR of 8.6% during the forecast period of 2022-2030. The main factors driving the growth would be increasing demand for private healthcare services, economic growth and rising income, regulatory reforms and technological advancements. The market is segmented by component, the provider, coverage, health insurance plans and end-user. Some of the major players include Bradesco Saude, Amil International Medical Assistance, Hapvida Sistema, Porto Seguro and Allianz.
Brazil Oncology Drugs Market Analysis
By 2030, it is anticipated that the Brazil oncology drugs market will reach a value of $12.7 Bn from $4.9 Bn in 2022, growing at a CAGR of 12.6% during 2022-2030. The oncology drug market in Brazil is dominated by a few large pharmaceutical companies such as EMS Pharma, Eurofarma, and Takeda Pharma. The oncology market in Brazil is segmented by different therapeutic areas and by different treatment types. The major factors affecting the Brazilian oncology drugs market are the high cost of the drugs, and the structured reimbursement system for the treatment.
Brazil Telemedicine Market Analysis
Brazil's telemedicine market size was valued at $1.52 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 19.2% from 2022 to 2030 and will reach $6.19 Bn in 2030. The increasing prevalence of chronic diseases is driving demand for telemedicine services that can help manage these conditions. The market is segmented by component type, application type, modality type, and by delivery mode type. Some of the key players in the market are Amil, Minha Vida, Televida, São Francisco Saúde, Doctoralia, and others.
Brazil Biosimilars Market Analysis
Brazil's biosimilars market size was valued at $0.4 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 23.2% from 2022 to 2030 and will reach $2.5 Bn in 2030. The market is segmented by product type and indication type. The Brazil Biosimilars market will grow with The increased incidence of chronic illnesses, rising healthcare expenses, and the demand for affordable biologic medicine substitutes. The key market players are Roche (CHE), Novartis (CHE), Pfizer (USA), Sanofi (FRA), Merck (USA), and others.
Brazil 3D Imaging Market Analysis
Brazil's 3D Imaging market is projected to grow from $0.76 Bn in 2022 to $2.76 Bn by 2030, registering a CAGR of 17.5% during the forecast period of 2022-30. The market will be driven by advancements in technology, increased investment, and the growing demand for more accurate and non-invasive diagnostic tools. The market is segmented by product, application, end-user & by portability. Some of the major players include GE Healthcare, Philips Healthcare & Siemens Healthineers
Brazil Depression Therapeutics Market Analysis
The Brazil depression therapeutics market is expected to witness growth from $253 Mn in 2022 to $409 Mn in 2030 with a CAGR of 6.2% for the forecasted year 2022-2030. The rise in healthcare spending and new research and development projects for depression treatment by various pharmaceutical firms in Brazil are responsible for the expansion of the market. The Brazil depression therapeutics market is segmented by drug type, therapies, indication, and by end users. Neo Química, Mantecorp Farmasa, and Elly Lilly are the major players in the Brazil depression therapeutics market.
Brazil Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Brazil liver cancer therapeutics market will reach a value of $286.7 Mn from $73.25 Mn in 2022, growing at a CAGR of 18.6% during 2022-30. The liver cancer therapeutics market in Brazil is dominated by a few domestic pharmaceutical companies such as Eurofarma, Aché Laboratórios, and Libbs Farmacêutica. The liver cancer therapeutics market in Brazil is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Brazil Cardiovascular Diseases Therapeutics Market Analysis
Brazil's cardiovascular disease therapeutics market is expected to witness growth from $4.06 Bn in 2022 to $7.64 Bn in 2030 with a CAGR of 8.22% for the forecasted year 2022-2030 due to the rising geriatric population and their subsequent demand for new and innovative therapeutic options in Brazil are responsible for the growth of the market. The Brazil cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by end user. Eurofarma, Cálamo Distribuidora, and Pfizer are the major players in the Brazil cardiovascular disease therapeutics market.
Brazil Artificial Intelligence (AI) in Healthcare Market Analysis
Brazil's Artificial Intelligence (AI) in Healthcare Market is projected to grow from $0.17 Bn in 2022 to $3.60 Bn by 2030, registering a CAGR of 46.22% during the forecast period of 2022-30. The market will be driven by the growing demand for healthcare services and the increasing availability of AI technologies. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Google Health, DASA & Inovacao AI.
Brazil Healthcare Claims Management Market Analysis
The Brazil healthcare claims management market is projected to grow from $667.5 Mn in 2022 to $3828.37 Mn by 2030, registering a CAGR of 24.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be increased adoption of value-based care, increasing demand for healthcare services, government initiatives and rising healthcare costs. The market is segmented by component, type, delivery mode and by end-user. Some of the major players include Bradesco Saude, Sinistro Facil, Amil, DXC Technology, Accenture and Cognizant.
